News und Analysen

Oncology-focused healthcare company Novocure (NASDAQ: NVCR) wasn't much of a cure for anyone's ill finances on Thursday. Its share price dived by nearly 8% on the day after management released its

Image source: The Motley Fool.

Merck (NYSE: MRK)Q3 2023 Earnings CallOct 26, 2023, 9:00 a.m. ET

Operator

Continue reading

Source Fool.com

If you want to beat the market, the key is having strong stocks in your portfolio of businesses that are profitable and growing. One name that has routinely outperformed the markets is health

If you want to beat the market, the key is having strong stocks in your portfolio of businesses that are profitable and growing. One name that has routinely outperformed the markets is health

The healthcare industry may not be as hot with investors as artificial intelligence or other high-flying industries, but the range of essential needs these businesses serve provides opportunities

The healthcare industry may not be as hot with investors as artificial intelligence or other high-flying industries, but the range of essential needs these businesses serve provides opportunities

The healthcare industry may not be as hot with investors as artificial intelligence or other high-flying industries, but the range of essential needs these businesses serve provides opportunities

While equity markets this year have recovered some of ground lost from the plunge of 2022, plenty of companies are still struggling. Some of them, though, clearly have the tools to rebound

It hasn't been the easiest of years for Johnson & Johnson (NYSE: JNJ), Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD). Shares of all three healthcare companies are trading flat or down amid

It hasn't been the easiest of years for Johnson & Johnson (NYSE: JNJ), Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD). Shares of all three healthcare companies are trading flat or down amid

It hasn't been the easiest of years for Johnson & Johnson (NYSE: JNJ), Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD). Shares of all three healthcare companies are trading flat or down amid

Vertex Pharmaceuticals (NASDAQ: VRTX) has climbed in the double digits this year and is trading around its highest ever. There are plenty of reasons for this top performance. The company continues

Vertex Pharmaceuticals (NASDAQ: VRTX) has climbed in the double digits this year and is trading around its highest ever. There are plenty of reasons for this top performance. The company continues

Vertex Pharmaceuticals (NASDAQ: VRTX) has climbed in the double digits this year and is trading around its highest ever. There are plenty of reasons for this top performance. The company continues

It hasn't been the easiest time for investors across a range of industries and sectors over the last few years. The good news is that when you're buying stocks to hold onto for anywhere from five

It hasn't been the easiest time for investors across a range of industries and sectors over the last few years. The good news is that when you're buying stocks to hold onto for anywhere from five

It hasn't been the easiest time for investors across a range of industries and sectors over the last few years. The good news is that when you're buying stocks to hold onto for anywhere from five

Shares of Alkermes (NASDAQ: ALKS) were sinking 7.9% as of 11:58 a.m. ET on Wednesday and had fallen as much as 13.1% earlier in the session. The decline came after the Ireland-based drugmaker

Over the past few years, we have witnessed several high-profile stock splits. Of course, these moves don't fundamentally change the value of a corporation. However, they can generate some buzz and

Over the past few years, we have witnessed several high-profile stock splits. Of course, these moves don't fundamentally change the value of a corporation. However, they can generate some buzz and

Over the past few years, we have witnessed several high-profile stock splits. Of course, these moves don't fundamentally change the value of a corporation. However, they can generate some buzz and

Are you looking for some exciting growth stocks to put in your portfolio? While some stocks may have risen to absurd valuations, there are still deals out there, especially for long-term investors

Are you looking for some exciting growth stocks to put in your portfolio? While some stocks may have risen to absurd valuations, there are still deals out there, especially for long-term investors

Are you looking for some exciting growth stocks to put in your portfolio? While some stocks may have risen to absurd valuations, there are still deals out there, especially for long-term investors

Did you know that if you have a high-yielding dividend stock that pays 5%, investing just $20,000 would be enough to generate $1,000 in annual dividend income? High-yielding stocks can be extremely